PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826FAB1V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $75,132
Award facts
- Contract value 100% obligated
- $75,132.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $75,132.13 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively through the DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program. As a critical pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp fulfills federal medical procurement requirements by supplying a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems.
This delivery order represents a child contract under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply vast ranges of medications and medical supplies to support military healthcare programs worldwide. The DLA's Pharmaceutical Prime Vendor Global Program Generation V contracting strategy involves multiple awards across separate regions with at least three different contractors, allowing AmerisourceBergen Drug Corp to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle.
Quick answers
Who was awarded contract SPE2D826FAB1V?
SPE2D826FAB1V was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on October 23, 2025.
How much is contract SPE2D826FAB1V worth?
The government has obligated $75,132 on SPE2D826FAB1V.
Is contract SPE2D826FAB1V an order under another contract?
Yes. SPE2D826FAB1V is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAB1V competed?
The extent of competition for SPE2D826FAB1V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award